Physician profile
Mackenzie Austgen
NPI 1477903391
$1,143.45
in general payments reported to CMS, 2019-2025
17 companies · $227 in 2025
The $227 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $59.83 · 2021: $381 · 2022: $154 · 2023: $167 · 2024: $154 · 2025: $227.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $548.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $548.35 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $202.80 | 2020-2025 | Lo Loestrin Fe |
| Pfizer INC. | $165.18 | 2021-2025 | |
| Aspira Women'S Health INC | $137.54 | 2021-2024 | Ova1 |
| Mayne Pharma Commercial LLC | $122.40 | 2022-2025 | |
| Exeltis, USA INC. | $113.30 | 2020-2025 | Slynd |
| Therapeuticsmd, INC. | $63.66 | 2021-2022 | |
| Gynesonics, INC. | $60.97 | 2023-2024 | Sonata Sonography-Guided Transcervical Fibroid Ablation System |
| Bayer Healthcare Pharmaceuticals INC. | $56.67 | 2021-2023 | |
| Biogen, INC. | $39.78 | 2025 | Zurzuvae |
| Hologic Sales and Service, LLC | $31.53 | 2021-2025 | Aptima |
| Astellas Pharma US INC | $28.82 | 2023 | Veozah |
| Avion Pharmaceuticals | $27.69 | 2023 | Balcoltra |
| Daiichi Sankyo INC. | $22.87 | 2020 | |
| Molnlycke Health Care US, LLC | $20.46 | 2024 | Mepilex Border Post-Op Ag |
| Shield Therapeutics INC | $17.69 | 2023 | Accrufer |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Minerva Surgical, INC | $16.41 | 2021 | |
| Exact Sciences Corporation | $15.68 | 2024 | Cologuard Collection Kit |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mackenzie Austgen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.